IL86502A - History of dihydrobenzopyran) or tetrahydronaphthalene (2) carboxylates converted by alkoxy and pharmaceutical preparations containing them - Google Patents

History of dihydrobenzopyran) or tetrahydronaphthalene (2) carboxylates converted by alkoxy and pharmaceutical preparations containing them

Info

Publication number
IL86502A
IL86502A IL8650288A IL8650288A IL86502A IL 86502 A IL86502 A IL 86502A IL 8650288 A IL8650288 A IL 8650288A IL 8650288 A IL8650288 A IL 8650288A IL 86502 A IL86502 A IL 86502A
Authority
IL
Israel
Prior art keywords
propyl
methoxy
dihydro
acetyl
methyl
Prior art date
Application number
IL8650288A
Other languages
English (en)
Hebrew (he)
Other versions
IL86502A0 (en
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of IL86502A0 publication Critical patent/IL86502A0/xx
Publication of IL86502A publication Critical patent/IL86502A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL8650288A 1987-05-29 1988-05-26 History of dihydrobenzopyran) or tetrahydronaphthalene (2) carboxylates converted by alkoxy and pharmaceutical preparations containing them IL86502A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5713687A 1987-05-29 1987-05-29
US07/188,708 US4889871A (en) 1987-05-29 1988-05-12 Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives

Publications (2)

Publication Number Publication Date
IL86502A0 IL86502A0 (en) 1988-11-15
IL86502A true IL86502A (en) 1994-07-31

Family

ID=26736113

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8650288A IL86502A (en) 1987-05-29 1988-05-26 History of dihydrobenzopyran) or tetrahydronaphthalene (2) carboxylates converted by alkoxy and pharmaceutical preparations containing them

Country Status (17)

Country Link
US (1) US4889871A (fr)
EP (1) EP0292977B1 (fr)
JP (1) JP2758902B2 (fr)
KR (1) KR880013914A (fr)
AU (1) AU611153B2 (fr)
CA (1) CA1337660C (fr)
DE (1) DE3864582D1 (fr)
DK (1) DK290188A (fr)
ES (1) ES2051796T3 (fr)
FI (1) FI882505A (fr)
GR (1) GR3003177T3 (fr)
IE (1) IE60687B1 (fr)
IL (1) IL86502A (fr)
NO (1) NO171063C (fr)
NZ (1) NZ224807A (fr)
PH (1) PH26153A (fr)
PT (1) PT87603B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300404A3 (fr) * 1987-07-20 1990-07-18 G.D. Searle & Co. Dérivés di- et tétrahydronaphtyliques comme agents anti-allergiques
IL89713A0 (en) * 1988-03-29 1989-09-28 Ciba Geigy Ag Novel alkanophenones
MA21528A1 (fr) * 1988-04-06 1989-12-31 Lipha Composants substituants du flavonoide, leurs sels, leurs manufactures et produits contenant ces matieres .
US5219883A (en) * 1988-05-20 1993-06-15 G. D. Searle & Co. 2,2-di-substituted benzopyran leukotriene-D4 antagonists
US4931574A (en) * 1988-08-23 1990-06-05 Hoffmann-La Roche Inc. Process for the preparation of benzopyrans
US5298512A (en) * 1989-04-07 1994-03-29 Pfizer Inc. Substituted chromans and their use in the treatment of asthma, arthritis and related diseases
US5073562A (en) * 1990-05-10 1991-12-17 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5192782A (en) * 1990-05-10 1993-03-09 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5212198A (en) * 1990-05-10 1993-05-18 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5051438A (en) * 1990-05-16 1991-09-24 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use
US5124350A (en) * 1990-06-28 1992-06-23 G. D. Searle & Co. Leukotriene b4 antagonists
FR2665159B1 (fr) * 1990-07-24 1992-11-13 Rhone Poulenc Sante Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
JP3334087B2 (ja) * 1990-09-10 2002-10-15 アヴェンティス ファーマシューティカルズ インコーポレイテッド 選択的ロイコトリエンb▲4▼拮抗剤活性を示す置換された二環式アリール化合物
US5488160A (en) * 1991-06-11 1996-01-30 Ciba-Geigy Corporation Amidino compounds, their manufacture and method of treatment
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
US5273999A (en) * 1991-09-10 1993-12-28 Hoffmann-La Roche Inc. Carboxylic acid leukotriene B4 antagonists
AU3172993A (en) * 1991-12-27 1993-07-28 Kureha Chemical Industry Co., Ltd. Oleaginous ointment
US5550152A (en) * 1992-01-23 1996-08-27 Pfizer Inc. Benzopyran and related LTB4 antagonists
HU216191B (hu) * 1992-02-05 1999-05-28 Boehringer Ingelheim Kg Eljárás új amidinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5352690A (en) * 1992-07-01 1994-10-04 Eli Lilly And Company 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists
JPH0625764A (ja) * 1992-07-08 1994-02-01 Sumitomo Metal Ind Ltd フェロスクラップ中の銅の除去・回収方法
US5324743A (en) * 1992-12-10 1994-06-28 Eli Lilly And Company Leukotriene B4 antagonists
DE4309285A1 (de) * 1993-03-23 1994-09-29 Boehringer Ingelheim Kg Heterocyclen enthaltende Amidinderivate, ihre Herstellung und Verwendung
US5380740A (en) * 1993-04-28 1995-01-10 G. D. Searle & Co. Anti-inflammatory compounds, compositions and method of use thereof
ES2084547B1 (es) * 1993-07-12 1997-01-16 Pfizer Antagonistas benzopiranicos y relacionados de leucotrieno b4.
US5457124A (en) * 1993-12-07 1995-10-10 Hoffmann-La Roche Inc. Carboxylic acid Leukotriene B4 antagonists
WO1995032201A1 (fr) * 1994-05-25 1995-11-30 G.D. Searle & Co. Derives de dihydrobenzopyrane-2-sulfonimides alcoxy-substitues, leur preparation et leur utilisation en tant qu'antagonistes de leucotriene b4
US5516917A (en) * 1994-06-08 1996-05-14 G. D. Searle & Co. Leukotriene B4 antagonists
WO1996006604A2 (fr) * 1994-08-31 1996-03-07 Eli Lilly And Company Procedes d'identification et de traitement de tumeurs resistantes
US5543428A (en) * 1994-08-31 1996-08-06 Eli Lilly And Company Method for treating resistant tumors
MX9702731A (es) * 1994-10-13 1997-06-28 Pfizer Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos.
KR100232340B1 (ko) * 1994-10-13 1999-12-01 디. 제이. 우드, 스피겔 알렌 제이 류코트리엔 b4(ltb4) 길항물질로서의 벤조피란 및 벤조-축합된 화합물
EP0836850A3 (fr) * 1996-10-17 2000-11-29 Pfizer Inc. Méthode pour prévenir le rejet d'allogreffes
ATE326960T1 (de) * 1998-08-28 2006-06-15 Intarcia Therapeutics Inc Zusammensetzungen zur linderung der nebeneffekte des interleukin-2
US6436987B1 (en) 2000-06-08 2002-08-20 Pfizer Inc. Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid
EP1324995A2 (fr) * 2000-09-27 2003-07-09 Merck & Co., Inc. Derives d'acide benzopyrancarboxylique utilises pour le traitement du diabete et des troubles lipidiques
EP1347755A2 (fr) 2000-10-31 2003-10-01 Merck & Co., Inc. Derives d'acide benzopyranocarboxylique pour traiter le diabete et d'autres troubles lipidiques
US20040242676A1 (en) * 2003-05-30 2004-12-02 Alessi Thomas R. Method of mitigating the adverse effects of IL-2
US8093253B2 (en) * 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
US4006245A (en) * 1971-07-29 1977-02-01 Fisons Limited Chemical compounds
DE3070912D1 (en) * 1979-03-20 1985-09-05 Fisons Plc Pharmaceutical heterocyclic compounds, processes for their preparation and compositions containing them
EP0079637B1 (fr) * 1981-11-12 1987-01-28 FISONS plc Dérivés d'acide carboxylique anti-srs-a, leurs procédés de production et formulation pharmaceutique les contenant
ZA844519B (en) * 1983-06-24 1985-02-27 Hoffmann La Roche Dihydrobenzopyran derivatives
AU548450B2 (en) * 1983-08-08 1985-12-12 G.D. Searle & Co. Substituted dihydrobenzopyrans
US4665203A (en) * 1983-08-08 1987-05-12 G. D. Searle & Co. Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
US4546194A (en) * 1984-05-29 1985-10-08 G. D. Searle & Co. Substituted chromanon-2-yl alkanols and derivatives thereof
DE3569062D1 (en) * 1985-06-28 1989-04-27 Ibm Shadow mask colour crt with enhanced resolution and/or brightness
ZA873745B (en) * 1986-06-04 1988-10-26 Daiichi Seiyaku Co Benzopyran derivatives
US4885309A (en) * 1986-08-01 1989-12-05 Hoffmann-La Roche Inc. Therapeutic treatment of leukotriene-mediated dermal inflammation by topical administration of 3,4-dihydro-2H-1-benzopyran derivatives

Also Published As

Publication number Publication date
US4889871A (en) 1989-12-26
NO171063B (no) 1992-10-12
CA1337660C (fr) 1995-11-28
DK290188D0 (da) 1988-05-27
AU1668188A (en) 1988-12-01
FI882505A (fi) 1988-11-30
DE3864582D1 (de) 1991-10-10
EP0292977B1 (fr) 1991-09-04
AU611153B2 (en) 1991-06-06
IE881611L (en) 1988-11-29
GR3003177T3 (en) 1993-02-17
NO882317L (no) 1988-11-30
JPS6438045A (en) 1989-02-08
IL86502A0 (en) 1988-11-15
PT87603A (pt) 1988-06-01
IE60687B1 (en) 1994-08-10
EP0292977A1 (fr) 1988-11-30
NO171063C (no) 1993-01-20
ES2051796T3 (es) 1994-07-01
PT87603B (pt) 1992-12-31
PH26153A (en) 1992-03-18
DK290188A (da) 1988-11-30
JP2758902B2 (ja) 1998-05-28
NO882317D0 (no) 1988-05-26
FI882505A0 (fi) 1988-05-27
NZ224807A (en) 1991-03-26
KR880013914A (ko) 1988-12-22

Similar Documents

Publication Publication Date Title
IL86502A (en) History of dihydrobenzopyran) or tetrahydronaphthalene (2) carboxylates converted by alkoxy and pharmaceutical preparations containing them
CA2081766C (fr) Antagonistes du leucotriene b4
US6166066A (en) Cannabinoids selective for the CB2 receptor
CA1087205A (fr) Acides 2-amino-3-(5-et 6-)benzoylphenylacetiques, leurs esters et sels metalliques
US4565818A (en) Pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline derivatives
GB2127402A (en) Pharmaceutically active carbostyril derivatives
KR910005706B1 (ko) 벤조티아진 유도체의 제조방법
US5516917A (en) Leukotriene B4 antagonists
Salman et al. Studies in antifertility agents. 50. Stereoselective binding of d-and l-centchromans to estrogen receptors and their antifertility activity
JPH06500791A (ja) 化合物
WO1991017989A1 (fr) Acides dihydrobenzopyran-2-carboxyliques a substitution alcoxy et leurs derives
US4312861A (en) Pharmaceutical compositions containing N-alkyl-N-(nuclearly-substituted) benzylamines having vasotonia-regulating activity
IE55991B1 (en) Bicyclic benzo fused compounds
NZ236534A (en) Method of treating inflammatory diseases
US4528372A (en) N-Phthalidyl-5-fluorouracils
GB1584925A (en) Aryl-hexafuranosides and processes for their preparation
KR840001613B1 (ko) 퀴놀론 화합물의 제조방법
US4539419A (en) Naphthalenyloxy substituted carboxylic acids
US4594442A (en) Naphthalenyloxy substituted carboxylic acids
KR790001695B1 (ko) 벤즈사이클로아미드 유도체의 제조법
US4870098A (en) Antagonists of leukotriene D4
US4666909A (en) Bisbenzothiazine, bisbenzodiazine and bisquinoline pharmaceutical compositions and use
Stealey et al. Antagonists of leukotriene D 4
JPS60146860A (ja) 有機化合物およびその薬剤使用
JPS6043341B2 (ja) カルボスチリル誘導体